Cargando…

Characteristics of DNA macro-alterations in breast cancer with liver metastasis before treatment

BACKGROUND: Whole-genome doubling (WGD) has been observed in 30% of cancers, followed by a highly complex rearranged karyotype unfavourable to breast cancer's outcome. However, the macro-alterations that characterise liver metastasis in breast cancer(BC) are poorly understood. Here, we conducte...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yu, Zou, Linglin, Zhong, Xiaorong, Wang, Zhu, Wang, Yu, Luo, Chuanxu, Zheng, Hong, Wang, Yanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334641/
https://www.ncbi.nlm.nih.gov/pubmed/37434117
http://dx.doi.org/10.1186/s12864-023-09497-w
_version_ 1785070901999435776
author Fan, Yu
Zou, Linglin
Zhong, Xiaorong
Wang, Zhu
Wang, Yu
Luo, Chuanxu
Zheng, Hong
Wang, Yanping
author_facet Fan, Yu
Zou, Linglin
Zhong, Xiaorong
Wang, Zhu
Wang, Yu
Luo, Chuanxu
Zheng, Hong
Wang, Yanping
author_sort Fan, Yu
collection PubMed
description BACKGROUND: Whole-genome doubling (WGD) has been observed in 30% of cancers, followed by a highly complex rearranged karyotype unfavourable to breast cancer's outcome. However, the macro-alterations that characterise liver metastasis in breast cancer(BC) are poorly understood. Here, we conducted a whole-genome sequencing analysis of liver metastases to explore the status and the time frame model of these macro-alterations in pre-treatment patients with metastatic breast cancer. RESULTS: Whole-genome sequencing was conducted in 11 paired primary tumours, lymph node metastasis, and liver metastasis fresh samples from four patients with late-stage breast cancer. We also chose five postoperative frozen specimens from patients with early-stage breast cancer before any treatment as control. Surprisingly, all four liver metastasis samples were classified as WGD + . However, the previous study reported that WGD happened in 30% of cancers and 2/5 in our early-stage samples. WGD was not observed in the two separate primary tumours and one lymph node metastasis of one patient with metastatic BC, but her liver metastasis showed an early burst of bi-allelic copy number gain. The phylogenetic tree proves her 4 tumour samples were the polyclonal origin and only one WGD + clone metastasis to the liver. Another 3 metastatic BC patients’ primary tumour and lymph node metastasis experienced WGD as well as liver metastasis, and they all showed similar molecular time-frame of copy number(CN) gain across locations within the same patient. These patients’ tumours were of monoclonal origin, and WGD happened in a founding clone before metastasis, explaining that all samples share the CN-gain time frame. After WGD, the genomes usually face instability to evolve other macro-alterations. For example, a greater quantity and variety of complex structural variations (SVs) were detected in WGD + samples. The breakpoints were enriched in the chr17: 39 Mb-40 Mb tile, which contained the HER2 gene, resulting in the formation of tyfonas, breakage-fusion-bridge cycles, and double minutes. These complex SVs may be involved in the evolutionary mechanisms of the dramatic increase of HER2 copy number. CONCLUSION: Our work revealed that the WGD + clone might be a critical evolution step for liver metastasis and favoured following complex SV of breast cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-023-09497-w.
format Online
Article
Text
id pubmed-10334641
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103346412023-07-12 Characteristics of DNA macro-alterations in breast cancer with liver metastasis before treatment Fan, Yu Zou, Linglin Zhong, Xiaorong Wang, Zhu Wang, Yu Luo, Chuanxu Zheng, Hong Wang, Yanping BMC Genomics Research BACKGROUND: Whole-genome doubling (WGD) has been observed in 30% of cancers, followed by a highly complex rearranged karyotype unfavourable to breast cancer's outcome. However, the macro-alterations that characterise liver metastasis in breast cancer(BC) are poorly understood. Here, we conducted a whole-genome sequencing analysis of liver metastases to explore the status and the time frame model of these macro-alterations in pre-treatment patients with metastatic breast cancer. RESULTS: Whole-genome sequencing was conducted in 11 paired primary tumours, lymph node metastasis, and liver metastasis fresh samples from four patients with late-stage breast cancer. We also chose five postoperative frozen specimens from patients with early-stage breast cancer before any treatment as control. Surprisingly, all four liver metastasis samples were classified as WGD + . However, the previous study reported that WGD happened in 30% of cancers and 2/5 in our early-stage samples. WGD was not observed in the two separate primary tumours and one lymph node metastasis of one patient with metastatic BC, but her liver metastasis showed an early burst of bi-allelic copy number gain. The phylogenetic tree proves her 4 tumour samples were the polyclonal origin and only one WGD + clone metastasis to the liver. Another 3 metastatic BC patients’ primary tumour and lymph node metastasis experienced WGD as well as liver metastasis, and they all showed similar molecular time-frame of copy number(CN) gain across locations within the same patient. These patients’ tumours were of monoclonal origin, and WGD happened in a founding clone before metastasis, explaining that all samples share the CN-gain time frame. After WGD, the genomes usually face instability to evolve other macro-alterations. For example, a greater quantity and variety of complex structural variations (SVs) were detected in WGD + samples. The breakpoints were enriched in the chr17: 39 Mb-40 Mb tile, which contained the HER2 gene, resulting in the formation of tyfonas, breakage-fusion-bridge cycles, and double minutes. These complex SVs may be involved in the evolutionary mechanisms of the dramatic increase of HER2 copy number. CONCLUSION: Our work revealed that the WGD + clone might be a critical evolution step for liver metastasis and favoured following complex SV of breast cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-023-09497-w. BioMed Central 2023-07-11 /pmc/articles/PMC10334641/ /pubmed/37434117 http://dx.doi.org/10.1186/s12864-023-09497-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Fan, Yu
Zou, Linglin
Zhong, Xiaorong
Wang, Zhu
Wang, Yu
Luo, Chuanxu
Zheng, Hong
Wang, Yanping
Characteristics of DNA macro-alterations in breast cancer with liver metastasis before treatment
title Characteristics of DNA macro-alterations in breast cancer with liver metastasis before treatment
title_full Characteristics of DNA macro-alterations in breast cancer with liver metastasis before treatment
title_fullStr Characteristics of DNA macro-alterations in breast cancer with liver metastasis before treatment
title_full_unstemmed Characteristics of DNA macro-alterations in breast cancer with liver metastasis before treatment
title_short Characteristics of DNA macro-alterations in breast cancer with liver metastasis before treatment
title_sort characteristics of dna macro-alterations in breast cancer with liver metastasis before treatment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334641/
https://www.ncbi.nlm.nih.gov/pubmed/37434117
http://dx.doi.org/10.1186/s12864-023-09497-w
work_keys_str_mv AT fanyu characteristicsofdnamacroalterationsinbreastcancerwithlivermetastasisbeforetreatment
AT zoulinglin characteristicsofdnamacroalterationsinbreastcancerwithlivermetastasisbeforetreatment
AT zhongxiaorong characteristicsofdnamacroalterationsinbreastcancerwithlivermetastasisbeforetreatment
AT wangzhu characteristicsofdnamacroalterationsinbreastcancerwithlivermetastasisbeforetreatment
AT wangyu characteristicsofdnamacroalterationsinbreastcancerwithlivermetastasisbeforetreatment
AT luochuanxu characteristicsofdnamacroalterationsinbreastcancerwithlivermetastasisbeforetreatment
AT zhenghong characteristicsofdnamacroalterationsinbreastcancerwithlivermetastasisbeforetreatment
AT wangyanping characteristicsofdnamacroalterationsinbreastcancerwithlivermetastasisbeforetreatment